<DOC>
	<DOCNO>NCT00116441</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy vaccination autologous myeloma cell allogeneic granulocyte-macrophage colony stimulate factor ( GM-CSF ) produce cell line .</brief_summary>
	<brief_title>Vaccination Peripheral Stem Cell Transplant Setting Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>De novo multiple myeloma ECOG 02 No serious comorbid illness adequate organ function &gt; 4 week systemic steroid No exist secondary malignancy history secondary malignancy past 5 year No active autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Cancer</keyword>
	<keyword>PSCT</keyword>
	<keyword>Peripheral Stem Cell Transplant</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>GVAX</keyword>
</DOC>